Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TAX PROVISION
Tax Provision HALO - Halozyme Therapeutics, Inc.
113 M
LAST VALUE
55.43%
2 YEAR CAGR
534.43%
5 YEAR CAGR
40.32%
10 YEAR CAGR